UAE Heparin Market Size & Outlook, 2023-2030
UAE heparin market, 2018-2030 (US$M)
Related Markets
UAE heparin market highlights
- The UAE heparin market generated a revenue of USD 20.3 million in 2023 and is expected to reach USD 26.3 million by 2030.
- The UAE market is expected to grow at a CAGR of 3.7% from 2024 to 2030.
- In terms of segment, porcine was the largest revenue generating source in 2023.
- Bovine is the most lucrative source segment registering the fastest growth during the forecast period.
Heparin market data book summary
| Market revenue in 2023 | USD 20.3 million |
| Market revenue in 2030 | USD 26.3 million |
| Growth rate | 3.7% (CAGR from 2023 to 2030) |
| Largest segment | Porcine |
| Fastest growing segment | Bovine |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Porcine, Bovine |
| Key market players worldwide | Pfizer Inc, Sanofi SA, Aspen Pharmacare Holdings Ltd, Fresenius SE & Co KGaA, Novartis AG ADR, GSK PLC ADR, Dr. Reddy’s Laboratories, LEO Pharma, B. Braun Medical |
Other key industry trends
- In terms of revenue, UAE accounted for 0.3% of the global heparin market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, Saudi Arabia heparin market is projected to lead the regional market in terms of revenue in 2030.
- South Africa is the fastest growing regional market in Middle East & Africa and is projected to reach USD 41.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Heparin Market Scope
Heparin Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UAE heparin market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to heparin market will help companies and investors design strategic landscapes.
Porcine was the largest segment with a revenue share of 88.18% in 2023. Horizon Databook has segmented the UAE heparin market based on porcine, bovine covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing epidemiology of chronic diseases is one of the major factors governing market growth. According to the Gulf News, in 2017, around 30% of all deaths in the UAE were caused by cardiovascular disease.
In addition, it was stated that this disease is primarily observed in young patients; around 20% of adults in the country are smokers. It is one of the greatest risk factors for cardiovascular disease in the region. As per CIA World Factbook’s 2016 data observations, the prevalence of adult obesity in UAE was 31.70% and it ranks 20th in the world.
In addition, the world atlas states that obesity-related illnesses have become a major financial burden on the country. As per the Gulf news, in 2019, 12,000 patients in the UAE suffer from stroke annually, with one person suffering from stroke every hour. These factors are expected to propel the demand for heparin.
Reasons to subscribe to UAE heparin market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UAE heparin market databook
-
Our clientele includes a mix of heparin market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE heparin market , including forecasts for subscribers. This country databook contains high-level insights into UAE heparin market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UAE heparin market size, by source, 2018-2030 (US$M)
UAE Heparin Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
